|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.830 USD | -0.51% |
|
+0.41% | +73.98% |
| Market Cap | 720M 630M 579M 539M 1.02B 68.58B 1.04B 6.95B 2.7B 33.71B 2.7B 2.65B 116B | P/E 2026 * |
-11x | P/E 2027 * | -17.2x |
|---|---|---|---|---|---|
| Enterprise Value | 720M 630M 579M 539M 1.02B 68.58B 1.04B 6.95B 2.7B 33.71B 2.7B 2.65B 116B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 13.7x |
| Free-Float |
84.3% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Candel Therapeutics, Inc.
| 1 day | -0.51% | ||
| 1 week | +0.41% | ||
| Current month | -4.56% | ||
| 1 month | +11.70% | ||
| 3 months | +96.60% | ||
| 6 months | +80.70% | ||
| Current year | +73.98% |
| 1 week | 9.57 |  | 11.36 |
| 1 month | 7.93 | | 11.36 |
| Current year | 4.44 | | 11.36 |
| 1 year | 4.35 | | 11.36 |
| 3 years | 0.66 | | 14.6 |
| 5 years | 0.66 | | 14.78 |
| 10 years | 0.66 | | 14.78 |
| Manager | Title | Age | Since |
|---|---|---|---|
Paul-Peter Tak
CEO | Chief Executive Officer | 66 | 2020-08-31 |
Charles Schoch
DFI | Director of Finance/CFO | 41 | 2024-01-11 |
Seshu Tyagarajan
CTO | Chief Tech/Sci/R&D Officer | 58 | 2022-03-01 |
| Director | Title | Age | Since |
|---|---|---|---|
Joseph Papa
BRD | Director/Board Member | 70 | 2022-08-07 |
Edward Benz
BRD | Director/Board Member | 80 | 2017-08-31 |
Paul Manning
CHM | Chairman | 70 | 2021-07-14 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-29 | Free | Chairman | 2,199 | 0.0030% | ||
| 06-29 | Free | Director | 381 | 0.0005% | ||
| 06-29 | Free | Director | 1,331 | 0.0018% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.51% | +0.41% | +92.75% | +686.40% | 720M | |
| +1.70% | +7.41% | +3.12% | +8.46% | 49.92B | |
| +0.92% | +3.93% | +399.71% | +605.33% | 40.23B | |
| +1.89% | +8.32% | +26.06% | -6.35% | 34.55B | |
| +2.38% | +6.35% | +21.25% | +64.58% | 33.09B | |
| +3.96% | +10.67% | +11.89% | +38.86% | 27.51B | |
| +2.51% | +5.27% | - | - | 17.05B | |
| +2.58% | +5.79% | +73.44% | +133.27% | 15.92B | |
| +0.32% | +0.58% | +13.67% | +19.09% | 13.86B | |
| +3.30% | +0.76% | +90.23% | +99.12% | 13.52B | |
| Average | +1.90% | +5.62% | +81.35% | +183.20% | 24.64B | |
| Weighted average by Cap. | +2.06% | +6.53% | +90.75% | +139.47% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 52.65M 46.03M 42.3M 39.43M 74.78M 5.01B 75.92M 508M 197M 2.46B 198M 193M 8.49B |
| Net income | -60.22M -52.65M -48.38M -45.1M -85.54M -5.73B -86.83M -581M -226M -2.82B -226M -221M -9.71B | -42.95M -37.55M -34.51M -32.16M -61M -4.09B -61.93M -414M -161M -2.01B -161M -158M -6.93B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-02 | US$9.830 | -0.51% | 1,550,102 |
| 26-07-01 | US$9.880 | -4.08% | 1,875,643 |
| 26-06-30 | US$10.30 | -0.58% | 2,943,146 |
| 26-06-29 | US$10.36 | +5.82% | 1,488,455 |
| 26-06-26 | US$9.790 | +3.38% | 4,925,638 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CADL Stock
Select your edition
All financial news and data tailored to specific country editions
